Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2016 | Microenvironment role in AML: talk overview

Dominique Bonnet • 6 Nov 2016
NCRI 2016
Acute Myeloid Leukemia

Dominique Bonnet, PhD of The Francis Crick Institute, London, UK discusses the role of the microenvironment in acute myeloid leukemia (AML). Targeting of the microenvironment could be a way to impede AML tumor growth. New tools are developed to modulate the leukemic stem cells by the bone marrow microenvironment. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.

More from Dominique Bonnet

3:41
Computational methods are the future of biological research
Dominique Bonnet • 4 May 2018
4:42
Non-invasive bone marrow screening to detect early leukemic cells
Dominique Bonnet • 4 May 2018
9:26
Understanding the evolution from haematopoietic stem cell to leukemic cell
Dominique Bonnet • 4 May 2018

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
2:22
Haplo-SCT for older patients with AML/MDS, and should age be a barrier to transplantation?
Raynier Devillier • 15 Apr 2024
1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals